Search Results - "Bakari, M"

Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults by Jongo, Said A, Church, L W Preston, Mtoro, Ali T, Schindler, Tobias, Chakravarty, Sumana, Ruben, Adam J, Swanson, Phillip A, Kassim, Kamaka R, Mpina, Maximillian, Tumbo, Anneth-Mwasi, Milando, Florence A, Qassim, Munira, Juma, Omar A, Bakari, Bakari M, Simon, Beatus, James, Eric R, Abebe, Yonas, KC, Natasha, Saverino, Elizabeth, Fink, Martina, Cosi, Glenda, Gondwe, Linda, Studer, Fabian, Styers, David, Seder, Robert A, Billingsley, Peter F, Daubenberger, Claudia, Sim, B Kim Lee, Tanner, Marcel, Richie, Thomas L, Abdulla, Salim, Hoffman, Stephen L

“…Abstract Background A vaccine would be an ideal tool for reducing malaria’s impact. PfSPZ Vaccine (radiation attenuated, aseptic, purified, cryopreserved…”
Get full text

Safety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants by Jongo, Said A, Church, L W Preston, Mtoro, Ali T, Chakravarty, Sumana, Ruben, Adam J, Swanson, Phillip A, Kassim, Kamaka R, Mpina, Maximillian, Tumbo, Anneth-Mwasi, Milando, Florence A, Qassim, Munira, Juma, Omar A, Bakari, Bakari M, Simon, Beatus, James, Eric R, Abebe, Yonas, Kc, Natasha, Saverino, Elizabeth, Gondwe, Linda, Studer, Fabian, Fink, Martina, Cosi, Glenda, El-Khorazaty, Jill, Styers, David, Seder, Robert A, Schindler, Tobias, Billingsley, Peter F, Daubenberger, Claudia, Sim, B Kim Lee, Tanner, Marcel, Richie, Thomas L, Abdulla, Salim, Hoffman, Stephen L

“…In 2016, there were more cases and deaths caused by malaria globally than in 2015. An effective vaccine would be an ideal additional tool for reducing…”
Get full text

Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults by Jongo, Said, Church, L W Preston, Milando, Florence, Qassim, Munira, Schindler, Tobias, Rashid, Mohammed, Tumbo, Anneth, Nyaulingo, Gloria, Bakari, Bakari M, Athuman Mbaga, Thabit, Mohamed, Latipha, Kassimu, Kamaka, Simon, Beatus S, Mpina, Maxmillian, Zaidi, Irfan, Duffy, Patrick E, Swanson, 2nd, Phillip A, Seder, Robert, Herman, Jonathan D, Mendu, Maanasa, Zur, Yonatan, Alter, Galit, Kc, Natasha, Riyahi, Pouria, Abebe, Yonas, Murshedkar, Tooba, James, Eric R, Billingsley, Peter F, Sim, B Kim Lee, Richie, Thomas L, Daubenberger, Claudia, Abdulla, Salim, Hoffman, Stephen L

“…BACKGROUNDSanaria PfSPZ Vaccine, composed of attenuated Plasmodium falciparum (Pf) sporozoites (SPZ), protects against malaria. We conducted this clinical…”
Get full text

Population Pharmacokinetics of Antimalarial Naphthoquine in Combination with Artemisinin in Tanzanian Children and Adults: Dose Optimization by Ali, Ali Mohamed, Gausi, Kamunkhwala, Jongo, Said A, Kassim, Kamaka R, Mkindi, Catherine, Simon, Beatus, Mtoro, Ali T, Juma, Omar A, Lweno, Omar N, Gwandu, Conrad H, Bakari, Bakari M, Mbaga, Thabiti A, Milando, Florence A, Hamad, Ali, Shekalaghe, Seif A, Abdulla, Salim, Denti, Paolo, Penny, Melissa A

“…The combination antimalarial therapy of artemisinin-naphthoquine (ART-NQ) was developed as a single-dose therapy, aiming to improve adherence relative to the…”
Get full text

Design of a Hybrid Energy System with Energy Storage for Standalone DC Microgrid Application by Juma, Mwaka I., Mwinyiwiwa, Bakari M. M., Msigwa, Consalva J., Mushi, Aviti T.

“…This paper presents microgrid-distributed energy resources (DERs) for a rural standalone system. It is made up of a solar photovoltaic (solar PV) system,…”
Get full text

EP15.02: Expectant management of preterm pre‐eclampsia: any benefit from umbilical artery Doppler velocimetry in a resource constrained setting? by Ehalaiye, B., Alkali, U. A., Bakari, M. A., Bulus, W. S., Enabudoso, E., Kaitafi, A. T., Lauwalu, F. G.

Get full text

Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults by Jongo, Said A, Shekalaghe, Seif A, Church, L W Preston, Ruben, Adam J, Schindler, Tobias, Zenklusen, Isabelle, Rutishauser, Tobias, Rothen, Julian, Tumbo, Anneth, Mkindi, Catherine, Mpina, Maximillian, Mtoro, Ali T, Ishizuka, Andrew S, Kassim, Kamaka Ramadhani, Milando, Florence A, Qassim, Munira, Juma, Omar A, Mwakasungula, Solomon, Simon, Beatus, James, Eric R, Abebe, Yonas, Kc, Natasha, Chakravarty, Sumana, Saverino, Elizabeth, Bakari, Bakari M, Billingsley, Peter F, Seder, Robert A, Daubenberger, Claudia, Sim, B Kim Lee, Richie, Thomas L, Tanner, Marcel, Abdulla, Salim, Hoffman, Stephen L

“…We are using controlled human malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious (Pf) sporozoites (SPZ) (PfSPZ Challenge)…”
Get full text

Randomized, controlled trial of a protein-calorie supplement for women coinfected with HIV-TB by Magohe, A., Kimario, J., Lukmanji, Z., Hendricks, K., Koethe, J. R., Neke, N. M., Tvaroha, S., Connor, R., Mackenzie, T., Waddell, R., Maro, I., Matee, M., Pallangyo, K., Bakari, M., Horsburgh, C. R., von Reyn, C. F.

Get full text

Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania by Tarimo, E A M, Bakari, M, Kakoko, D C V, Kohi, T W, Mhalu, F, Sandstrom, E, Kulane, A

“…The search for an efficacious HIV vaccine is a global priority. To date only one HIV vaccine trial (RV144) has shown modest efficacy in a phase III trial. With…”
Get full text

Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment by Ngaimisi, E, Minzi, O, Mugusi, S, Sasi, P, Riedel, K-D, Suda, A, Ueda, N, Bakari, M, Janabi, M, Mugusi, F, Bertilsson, L, Burhenne, J, Aklillu, E, Diczfalusy, U

“…To assess the effect of the major efavirenz metabolizing enzyme (CYP2B6) genotype and the effects of rifampicin co-treatment on induction of CYP3A by…”
Get full text

A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol by Alam, T, Ahmed, D, Ahmed, T, Chisti, M. J, Rahman, M. W, Asthana, A. K, Bansal, P. K, Chouhan, A, Deb, S, Dhingra, P, Dhingra, U, Dutta, A, Jaiswal, V. K, Kumar, J, Pandey, A, Sazawal, S, Sharma, A. K, McGrath, C, Nyabinda, C, Okello, M, Pavlinac, P. B, Singa, B, Walson, J. L, Bar-Zeev, N, Dube, Q, Freyne, B, Ndamala, C, Ndeketa, L, Badji, H, Booth, J. P, Coulibaly, F, Haidara, F, Kotloff, K, Malle, D, Mehta, A, Sow, S, Tapia, M, Tennant, S, Hotwani, A, Kabir, F, Qamar, F, Qureshi, S, Shakoor, S, Thobani, R, Yousufzai, M. T, Bakari, M, Duggan, C, Kibwana, U, Kisenge, R, Manji, K, Somji, S, Sudfeld, C, Ashorn, P, Bahl, R, De Costa, A, Simon, J

“…Acute diarrhoea is a common cause of illness and death among children in low- to middle-income settings. World Health Organization guidelines for the clinical…”
Get full text

High Rates of Clinical and Subclinical Tuberculosis among HIV-Infected Ambulatory Subjects in Tanzania by Mtei, Lillian, Matee, Mecky, Herfort, Oliver, Bakari, Muhammad, Horsburgh, C. Robert, Waddell, Richard, Cole, Bernard F., Vuola, Jenni M., Tvaroha, Susan, Kreiswirth, Barry, Pallangyo, Kisali, von Reyn, C. Fordham

“…Background We sought to determine the prevalence of active tuberculosis among ambulatory HIV-infected persons in Tanzania with CD4 cell counts of ⩾200…”
Get full text

Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4 -hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment by Ngaimisi, E., Minzi, O., Mugusi, S., Sasi, P., Riedel, K.- D., Suda, A., Ueda, N., Bakari, M., Janabi, M., Mugusi, F., Bertilsson, L., Burhenne, J., Aklillu, E., Diczfalusy, U.

“…To assess the effect of the major efavirenz metabolizing enzyme (CYP2B6) genotype and the effects of rifampicin co-treatment on induction of CYP3A by…”
Get full text

Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality by VON REYN, C. F, KIMAMBO, S, MACKENZIE, T, LYIMO, J, TVAROHA, S, WADDELL, R, KREISWIRTH, B, HORSBURGH, C. R, PALLANGYO, K, MTEI, L, ARBEIT, R. D, MARO, I, BAKARI, M, MATEE, M, LAHEY, T, ADAMS, L. V, BLACK, W

“…BACKGROUND: Disseminated tuberculosis (TB) is a major cause of death in patients with the acquired immune-deficiency syndrome (AIDS), but its pathogenesis and…”
Get full text

Enhancing adherence to antiretroviral therapy at the HIV clinic in resource constrained countries; the Tanzanian experience by Mugusi, F., Mugusi, S., Bakari, M., Hejdemann, B., Josiah, R., Janabi, M., Aboud, S., Aris, E., Swai, H., Mhalu, F., Biberfeld, G., Pallangyo, K., Sandstrom, E.

“…Summary Objective  To evaluate various strategies aimed at improving adherence to antiretroviral therapy (ART). Methods  Patients initiated on ART at Muhimbili…”
Get full text

Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania by KABALI, C, VON REYN, C. F, BROOKS, D. R, WADDELL, R, MTEI, L, BAKARI, M, MATEE, M, PALLANGYO, K, ARBEIT, R. D, HORSBURGH, C. R

“…SETTING: The World Health Organization recommends the use of isoniazid preventive therapy (IPT) for human immunodeficiency virus (HIV) infected patients with a…”
Get full text

Low BMI and falling BMI predict HIV-associated tuberculosis: a prospective study in Tanzania by MARO, I, LAHEY, T, MACKENZIE, T, MTEI, L, BAKARI, M, MATEE, M, PALLANGYO, K, VON REYN, C. F

“…BACKGROUND: Low body mass index (BMI) is a known risk factor for tuberculosis (TB) in people without human immunodeficiency virus (HIV), but there are no…”
Get full text

New vaccines for the prevention of tuberculosis in human immunodeficiency virus infection [Perspectives] by von Reyn, C. F., Bakari, M., Arbeit, R. D., Lahey, T., Ramadhani, A., Egwaga, S.

“…The prevention of human immunodeficiency virus (HIV) associated tuberculosis (TB) remains challenging. Several vaccines against TB have advanced to clinical…”
Get full text

Enrolment and logistical challenges in TaMoVac 01 Phase I/II HIV trial despite the completion of an earlier (HIVIS-03 trial trial) in Dar es Salaam by Ngatoluwa, M, Munseri, P, Janabi, M, Mhalu, F, Sandstrom, E, Bakari, M

“…Doc number: P153…”
Get full text

In reply to 'Completion of isoniazid preventive therapy and survival in HIV-infected TST-positive adults in Tanzania' [Correspondence] by Kabali, C., von Reyn, C. F., Brooks, D. R., Waddell, R., Mtei, L., Bakari, M., Matee, M., Pallangyo, K., Arbeit, R. D., Horsburgh Jr, C. R.

Get full text